Publication:
The Parkinson's Disease Mendelian Randomization Research Portal.

dc.contributor.authorNoyce, Alastair J
dc.contributor.authorBandres-Ciga, Sara
dc.contributor.authorKim, Jonggeol
dc.contributor.authorHeilbron, Karl
dc.contributor.authorKia, Demis
dc.contributor.authorHemani, Gibran
dc.contributor.authorXue, Angli
dc.contributor.authorLawlor, Debbie A
dc.contributor.authorSmith, George Davey
dc.contributor.authorDuran, Raquel
dc.contributor.authorGan-Or, Ziv
dc.contributor.authorBlauwendraat, Cornelis
dc.contributor.authorGibbs, J Raphael
dc.contributor.authorHinds, David A
dc.contributor.authorYang, Jian
dc.contributor.authorVisscher, Peter
dc.contributor.authorCuzick, Jack
dc.contributor.authorMorris, Huw
dc.contributor.authorHardy, John
dc.contributor.authorWood, Nicholas W
dc.contributor.authorNalls, Mike A
dc.contributor.authorSingleton, Andrew B
dc.contributor.group23andMe Research Team5, International Parkinson's Disease Genomics Consortium (IPDGC)
dc.date.accessioned2023-02-08T14:48:28Z
dc.date.available2023-02-08T14:48:28Z
dc.date.issued2019-08-05
dc.description.abstractMendelian randomization is a method for exploring observational associations to find evidence of causality. To apply Mendelian randomization between risk factors/phenotypic traits (exposures) and PD in a large, unbiased manner, and to create a public resource for research. We used two-sample Mendelian randomization in which the summary statistics relating to single-nucleotide polymorphisms from 5,839 genome-wide association studies of exposures were used to assess causal relationships with PD. We selected the highest-quality exposure genome-wide association studies for this report (n = 401). For the disease outcome, summary statistics from the largest published PD genome-wide association studies were used. For each exposure, the causal effect on PD was assessed using the inverse variance weighted method, followed by a range of sensitivity analyses. We used a false discovery rate of 5% from the inverse variance weighted analysis to prioritize exposures of interest. We observed evidence for causal associations between 12 exposures and risk of PD. Of these, nine were effects related to increasing adiposity and decreasing risk of PD. The remaining top three exposures that affected PD risk were tea drinking, time spent watching television, and forced vital capacity, but these may have been biased and were less convincing. Other exposures at nominal statistical significance included inverse effects of smoking and alcohol. We present a new platform which offers Mendelian randomization analyses for a total of 5,839 genome-wide association studies versus the largest PD genome-wide association studies available (https://pdgenetics.shinyapps.io/MRportal/). Alongside, we report further evidence to support a causal role for adiposity on lowering the risk of PD. © 2019 The Authors. Movement Disorders published by Wiley Periodicals, Inc. on behalf of International Parkinson and Movement Disorder Society.
dc.description.versionSi
dc.identifier.citationNoyce AJ, Bandres-Ciga S, Kim J, Heilbron K, Kia D, Hemani G, et al. The Parkinson's Disease Mendelian Randomization Research Portal. Mov Disord. 2019 Dec;34(12):1864-1872.
dc.identifier.doi10.1002/mds.27873
dc.identifier.essn1531-8257
dc.identifier.pmcPMC6973052
dc.identifier.pmid31659794
dc.identifier.pubmedURLhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6973052/pdf
dc.identifier.unpaywallURLhttps://movementdisorders.onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.27873
dc.identifier.urihttp://hdl.handle.net/10668/15488
dc.issue.number12
dc.journal.titleMovement disorders : official journal of the Movement Disorder Society
dc.journal.titleabbreviationMov Disord
dc.language.isoen
dc.organizationInstituto de Investigación Biosanitaria ibs. GRANADA
dc.page.number1864-1872
dc.provenanceRealizada la curación de contenido 27/08/2024
dc.publisherJohn Wiley & Sons, Inc.
dc.pubmedtypeJournal Article
dc.pubmedtypeResearch Support, N.I.H., Intramural
dc.pubmedtypeResearch Support, Non-U.S. Gov't
dc.relation.publisherversionhttps://doi.org/10.1002/mds.27873
dc.rightsAttribution 4.0 International
dc.rights.accessRightsopen access
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subjectMendelian randomization
dc.subjectParkinson's disease
dc.subjectpublic resource
dc.subjectrisk factor
dc.subject.decsAdulto
dc.subject.decsAnciano
dc.subject.decsAnálisis de la aleatorización Mendeliana
dc.subject.decsCapacidad vital
dc.subject.decsCausalidad
dc.subject.decsEstudio de asociación del genoma completo
dc.subject.decsFenotipo
dc.subject.decsHumanos
dc.subject.decsPersona de mediana edad
dc.subject.decsPolimorfismo de nucleótido simple
dc.subject.decsPredisposición genética a la enfermedad
dc.subject.decsResultado del tratamiento
dc.subject.decsTelevisión
dc.subject.decs
dc.subject.meshAdult
dc.subject.meshAged
dc.subject.meshAged, 80 and over
dc.subject.meshCausality
dc.subject.meshFemale
dc.subject.meshGenetic Predisposition to Disease
dc.subject.meshGenome-Wide Association Study
dc.subject.meshHumans
dc.subject.meshMale
dc.subject.meshMendelian Randomization Analysis
dc.subject.meshMiddle Aged
dc.subject.meshPhenotype
dc.subject.meshPolymorphism, Single Nucleotide
dc.subject.meshTea
dc.subject.meshTelevision
dc.subject.meshTreatment Outcome
dc.subject.meshVital Capacity
dc.titleThe Parkinson's Disease Mendelian Randomization Research Portal.
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number34
dspace.entity.typePublication

Files

Original bundle

Now showing 1 - 2 of 2
Loading...
Thumbnail Image
Name:
PMC6973052.pdf
Size:
404.95 KB
Format:
Adobe Portable Document Format
Loading...
Thumbnail Image
Name:
Noyce_TheParkinson's_MaterialSuplementario.pdf
Size:
1.6 MB
Format:
Adobe Portable Document Format